Wockhardt Limited

WOCKPHARMA

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026580

    Quarter₹ croreYoY
    Sept 2024370+42.3%
    Dec 2024325+12.8%
    Mar 20253550.0%
    Jun 2025413+17.3%
    Sept 2025380+2.7%
    Dec 2025430+32.3%
    Mar 2026516+45.4%
    Jun 2026561+35.8%
    Sept 2026580+52.6%
  • ₹ crore

    Sept 202621

    Quarter₹ crore
    Sept 202411
    Dec 20246
    Mar 202514
    Jun 202525
    Sept 202530
    Dec 202527
    Mar 202655
    Jun 202633
    Sept 202621
  • ₹ crore

    Sept 2026601

    Quarter₹ crore
    Sept 2024381
    Dec 2024331
    Mar 2025369
    Jun 2025438
    Sept 2025410
    Dec 2025457
    Mar 2026571
    Jun 2026594
    Sept 2026601
  • Cost structure
  • ₹ crore

    Sept 202696

    Quarter₹ crore
    Sept 202465
    Dec 202471
    Mar 202564
    Jun 202568
    Sept 202588
    Dec 202578
    Mar 202679
    Jun 202685
    Sept 202696
  • ₹ crore

    Sept 2026501

    Quarter₹ crore
    Sept 2024417
    Dec 2024353
    Mar 2025329
    Jun 2025369
    Sept 2025356
    Dec 2025419
    Mar 2026439
    Jun 2026487
    Sept 2026501
  • Exceptional items and tax
  • ₹ crore

    Sept 2026100

    Quarter₹ crore
    Sept 2024-36
    Dec 2024-22
    Mar 202540
    Jun 202569
    Sept 202554
    Dec 202528
    Mar 2026167
    Jun 2026107
    Sept 2026100
  • ₹ crore

    Sept 20260

    Quarter₹ crore
    Sept 20240
    Dec 20240
    Mar 20250
    Jun 20250
    Sept 20250
    Dec 20250
    Mar 20260
    Jun 20260
    Sept 20260
  • Profit
  • ₹ crore

    Sept 2026100

    Quarter₹ croreYoY
    Sept 2024-36+66.4%*
    Dec 2024-22+70.3%*
    Mar 202540+131.7%*
    Jun 202569+1050.0%
    Sept 202554+250.0%*
    Dec 202528+227.3%*
    Mar 2026167+317.5%
    Jun 2026107+55.1%
    Sept 2026100+85.2%
  • Per share
  • ₹ per share

    Sept 20266.15

    Quarter₹ per share
    Sept 2024-2.34
    Dec 2024-1.40
    Mar 20252.47
    Jun 20254.25
    Sept 20253.26
    Dec 20251.73
    Mar 202610.29
    Jun 20266.62
    Sept 20266.15
  • Leverage
  • Debt to equity

    times

    Sept 20260.00x

    Quartertimes
    Sept 20240.00x
    Dec 20240.00x
    Mar 2025—
    Jun 2025—
    Sept 20250.00x
    Dec 20250.00x
    Mar 2026—
    Jun 2026—
    Sept 20260.00x
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
370325355413380430516561580
Revenue YoY+42.3%+12.8%0.0%+17.3%+2.7%+32.3%+45.4%+35.8%+52.6%
11614253027553321
381331369438410457571594601
Cost structure
657164688878798596
417353329369356419439487501
Exceptional items and tax
-36-2240695428167107100
000000000
Profit
-36-2240695428167107100
Net profit YoY+66.4%*+70.3%*+131.7%*+1050.0%+250.0%*+227.3%*+317.5%+55.1%+85.2%
Per share
-2.34-1.402.474.253.261.7310.296.626.15
Leverage
Debt to equity0.00x0.00x——0.00x0.00x——0.00x

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.